TrianglePUBLICATIONS · 23109692
Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2013 Jan 1
- First author
- Damaj G
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Damaj G
- type
- Author
- name
- Gressin R
- type
- Author
- name
- Bouabdallah K
- type
- Author
- name
- Cartron G
- type
- Author
- name
- Choufi B
- type
- Author
- name
- Gyan E
- type
- Author
- name
- Banos A
- type
- Author
- name
- Jaccard A
- type
- Author
- name
- Park S
- type
- Author
- name
- Tournilhac O
- type
- Author
- name
- Schiano-de Collela JM
- type
- Author
- name
- Voillat L
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Damaj G
- type
- Author
- name
- Gressin R
- type
- Author
- name
- Bouabdallah K
- type
- Author
- name
- Cartron G
- type
- Author
- name
- Choufi B
- type
- Author
- name
- Gyan E
- type
- Author
- name
- Banos A
- type
- Author
- name
- Jaccard A
- type
- Author
- name
- Park S
- type
- Author
- name
- Tournilhac O
- type
- Author
- name
- Schiano-de Collela JM
- type
- Author
- name
- Voillat L
- type
- Author
- bibliography ids
- nci-bib-fa7b86af98ff6674e9b11fd4
- book metadata
- content sha256
- 92dd549ae3f8712a14ca3222b8783cdb36461159cd53574715e7610ef5f79165
- document type
- citation
- dois
- 10.1200/JCO.2012.43.7285
- electronic publication date
- display
- 2012 Oct 29
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23109692
- immutable id
- pubmed:23109692@92dd549ae3f8712a14ca3222b8783cdb36461159cd53574715e7610ef5f79165
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 1
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 104-10
- volume
- 31
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23109692
- provenance
- batch id
- 99e85dbb34a1a3011c9a
- provider
- NCBI PubMed ESummary
- record sha256
- 0900e889ea7844e95ae7ea43ca5328a875e7e1ae3027e30a4169f3ab503023d8
- response sha256
- 1f4a46dcee9da36f8f58fe356dce3f44a1b3004f404e9fb0184f4e08aed4acf2
- retrieved at
- 2026-09-09T23:46:52.860383+00:00
- publication date
- display
- 2013 Jan 1
- precision
- day
- year
- 2013
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial.
Preserved source evidence · Independent clinical review pending · Not medical advice